Centro Nacional de Investigaciones Cardiovasculares Carlos III-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2016

  1. First-in-class inhibitor of the T cell receptor for the treatment of autoimmune diseases

    Science Translational Medicine, Vol. 8, Núm. 370